Creganna-Tactx Medical has a new Chairman
Scott R. Ward has been appointed Chairman of Creganna-Tactx Medical. He will succeed Ian Quinn, the company founder, who will continue as a non-executive director of the Board.
Scott Ward, who has had a long career in the medical device industry, first joined the Board of Creganna-Tactx Medical in 2011. As former Vice President & President of Medtronic CardioVascular, he was responsible for the worldwide operations of the Coronary, Peripheral, Endovascular and Structural Heart Disease business units at the company.
Welcoming his appointment, Mr Ward said, "I look forward to working closely with the Management and Board to deliver the company’s next phase of growth. Building on its current market leadership positions, the company is well placed to explore new avenues for development and expansion in a dynamic market environment.”
Helen Ryan, Creganna-Tactx Medical CEO said, "I would like to thank Mr Quinn for his support over the past eight years and I look forward to working with Mr Ward as our new Chairman. He brings a wealth of industry knowledge and experience which will be of great benefit to the management team as we embark on a new phase in the development of the business.”
In addition to his appointment as Chairman of the Creganna-Tactx Medical Board, Mr Ward is Chairman to the Board of MAP Pharmaceuticals Inc and Gillette Children’s Specialty Healthcare and a member of the Board of SurModics Inc.
Creganna-Tactx Medical is ranked among the top 10 global companies in the medical device outsourcing industry. It specialises in technologies, products and services for minimally invasive device solutions. Headquartered in Galway, Ireland, the company has facilities spanning US, Europe and Asia.